Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Indivior ( (INDV) ) is now available.
On March 17, 2026, Indivior Pharmaceuticals, Inc. issued $500 million of 0.625% Convertible Senior Notes due 2031, including $50 million from the full exercise of an option granted to initial purchasers, with the notes ranking as senior unsecured obligations and carrying an initial conversion price of about $41.66 per share, a 35% premium to the March 12, 2026 Nasdaq closing price. The financing, sold privately to qualified institutional buyers, provides low-cost, flexible capital and, on the same date, Indivior used part of the proceeds to fully prepay and terminate a prior Note Purchase Agreement dated November 4, 2024, simplifying its capital structure and potentially reducing future interest and covenant burdens for stakeholders.
The most recent analyst rating on (INDV) stock is a Hold with a $31.00 price target. To see the full list of analyst forecasts on Indivior stock, see the INDV Stock Forecast page.
Spark’s Take on INDV Stock
According to Spark, TipRanks’ AI Analyst, INDV is a Neutral.
The score is held back primarily by weak cash-flow consistency and balance-sheet constraints (negative equity), with additional pressure from bearish technicals. Offsetting these, management’s 2026 outlook points to strong EBITDA and cash-flow improvement and valuation is moderate, while recent refinancing/buyback actions modestly support financial flexibility.
To see Spark’s full report on INDV stock, click here.
More about Indivior
Indivior Pharmaceuticals, Inc. operates in the pharmaceuticals industry, focusing on the development and commercialization of prescription medicines. The company is listed on The Nasdaq Global Select Market and issues common stock, which serves as the underlying equity for its convertible debt instruments.
Average Trading Volume: 2,542,448
Technical Sentiment Signal: Buy
Current Market Cap: $3.87B
For a thorough assessment of INDV stock, go to TipRanks’ Stock Analysis page.